Rare and Orphan Diseases

Episodes 1-12 of 12

• 

  RestartResume

  Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies

  Medical Industry Feature

  Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies

  • 

    

    Gates B. Colbert, MD

    Peer

  • 

    

    Uma Borate, MD

    Peer

  • 

    

    James Dugan, MD

    Peer

• 

  RestartResume

  Expert Insights on Adult Congenital Adrenal Hyperplasia Care

  Medical Industry Feature

  Expert Insights on Adult Congenital Adrenal Hyperplasia Care

  • 

    

    Sara Lubitz, MD

    Peer

• 

  RestartResume

  Expert Insights on Congenital Adrenal Hyperplasia Care From an Adult Endocrinologist

  Medical Industry Feature

  Expert Insights on Congenital Adrenal Hyperplasia Care From an Adult Endocrinologist

  • 

    

    Sara Lubitz, MD

    Peer

• 

  RestartResume

  Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment

  Medical Industry Feature

  Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Thomas Brannagan III, MD

    Peer

• 

  RestartResume

  Breaking Down ATTR Pathophysiology

  Medical Industry Feature

  Breaking Down ATTR Pathophysiology

  • 

    

    Marcus Anthony Urey, MD

    Peer

• 

  RestartResume

  Considerations for Time-limited Treatment in 1L Treatment Selection Decisions

  Medical Industry Feature

  Considerations for Time-limited Treatment in 1L Treatment Selection Decisions

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Matthew Cortese, MD, MPH

    Peer

• 

  RestartResume

  Navigating the Complexities of Sickle Cell Disease: An Expert Perspective

  Medical Industry Feature

  Navigating the Complexities of Sickle Cell Disease: An Expert Perspective

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Samuel R. Wilson, MD

    Peer

• 

  RestartResume

  IgAN Insights: The Potential Role of the Complement System in Disease Progression

  Medical Industry Feature

  IgAN Insights: The Potential Role of the Complement System in Disease Progression

  • 

    

    Jean Francis, MD

    Peer

• 

  RestartResume

  Identifying Patients at High-Risk for IgAN Progression: Key Factors to Know

  Medical Industry Feature

  Identifying Patients at High-Risk for IgAN Progression: Key Factors to Know

  • 

    

    Jean Francis, MD

    Peer

  • 

    

    Anthony Chang, MD

    Peer

• 

  RestartResume

  Managing Refractory Cytomegalovirus Post-Solid Organ Transplant

  Medical Industry Feature

  Managing Refractory Cytomegalovirus Post-Solid Organ Transplant

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Suphamai Bunnapradist, MD, MS, FACP

    Peer

• 

  RestartResume

  Managing Refractory Cytomegalovirus After Hematopoietic Cell Transplant

  Medical Industry Feature

  Managing Refractory Cytomegalovirus After Hematopoietic Cell Transplant

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Amir Ali, PharmD, BCOP

    Peer

• 

  RestartResume

  Investigating Imaging Techniques in Multiple Myeloma

  Medical Industry Feature

  Investigating Imaging Techniques in Multiple Myeloma

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Jens Hillengass, MD, PhD

    Peer